Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000154152 | SCV000203818 | benign | not specified | 2014-02-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001719953 | SCV000209399 | benign | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000869727 | SCV001011178 | likely benign | Mowat-Wilson syndrome | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000869727 | SCV002045676 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415652 | SCV002725532 | benign | Inborn genetic diseases | 2019-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003937439 | SCV004747313 | likely benign | ZEB2-related disorder | 2019-08-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |